Whole genome sequencing of Mycobacterium tuberculosis

Next-generation sequencing approaches promise to become the future standard for drug-susceptibility testing and epidemiological investigation in tuberculosis and for other high-priority bacterial pathogens http://ow.ly/kXsV30lLP78

[1]  S. Niemann,et al.  Aiming for zero tuberculosis transmission in low-burden countries. , 2017, The Lancet. Respiratory medicine.

[2]  Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis , 2019, Antimicrobial Agents and Chemotherapy.

[3]  D. Chin,et al.  Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study , 2018, The Lancet. Infectious diseases.

[4]  N Woodford,et al.  The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture , 2018 .

[6]  Zhaogang Sun,et al.  Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes , 2017, Annals of Clinical Microbiology and Antimicrobials.

[7]  M. Pai,et al.  Real-Time Sequencing of Mycobacterium tuberculosis: Are We There Yet? , 2017, Journal of Clinical Microbiology.

[8]  J. G. Patton,et al.  Strain-specific suppression of microRNA-320 by carcinogenic Helicobacter pylori promotes expression of the antiapoptotic protein Mcl-1. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[9]  T. Clark,et al.  Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to action. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[10]  N. Segata,et al.  The new phylogeny of the genus Mycobacterium: The old and the news. , 2017, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[11]  D. van Soolingen,et al.  WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing. , 2019, The Journal of antimicrobial chemotherapy.

[12]  L. Chindelevitch,et al.  Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase , 2018, Scientific Reports.

[13]  S. Niemann,et al.  Isoniazid resistance in Mycobacterium tuberculosis is a heterogeneous phenotype comprised of overlapping MIC distributions with different underlying resistance mechanisms , 2019, bioRxiv.

[14]  Joanne R. Winter,et al.  Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review , 2016, BMC Medicine.

[15]  Nalin Rastogi,et al.  Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage , 2015, Nature Genetics.

[16]  Stefan Niemann,et al.  Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools , 2017, Scientific Reports.

[17]  T. Clark,et al.  Use of whole genome sequencing in surveillance of drug resistant tuberculosis , 2018, Expert review of anti-infective therapy.

[18]  S. Niemann,et al.  Whole Genome Sequencing Reveals Complex Evolution Patterns of Multidrug-Resistant Mycobacterium tuberculosis Beijing Strains in Patients , 2013, PloS one.

[19]  Phelim Bradley,et al.  Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study , 2015, The Lancet. Infectious diseases.

[20]  Phelim Bradley,et al.  DNA Sequencing Predicts 1st-Line Tuberculosis Drug Susceptibility Profiles , 2018, The New England journal of medicine.

[21]  G. Sotgiu,et al.  Genotypic and phenotypic M. tuberculosis resistance: guiding clinicians to prescribe the correct regimens , 2017, European Respiratory Journal.

[22]  Tamara Munzner,et al.  Evidence-based design and evaluation of a whole genome sequencing clinical report for the reference microbiology laboratory , 2017, bioRxiv.

[23]  G. Weinstock,et al.  Making the Leap from Research Laboratory to Clinic: Challenges and Opportunities for Next-Generation Sequencing in Infectious Disease Diagnostics , 2015, mBio.

[24]  J Moran-Gilad,et al.  Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[25]  M. Huynen,et al.  Whole-Genome Sequencing of Bacterial Pathogens: the Future of Nosocomial Outbreak Analysis , 2017, Clinical Microbiology Reviews.

[26]  G. Rossolini,et al.  Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries , 2018, European Respiratory Journal.

[27]  E Trees,et al.  Next-generation sequencing technologies and their application to the study and control of bacterial infections. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[28]  K. Steingart,et al.  Diagnostic Accuracy and Reproducibility of WHO-Endorsed Phenotypic Drug Susceptibility Testing Methods for First-Line and Second-Line Antituberculosis Drugs , 2012, Journal of Clinical Microbiology.

[29]  Phelim Bradley,et al.  Same-Day Diagnostic and Surveillance Data for Tuberculosis via Whole-Genome Sequencing of Direct Respiratory Samples , 2016, Journal of Clinical Microbiology.

[30]  S. Niemann,et al.  Whole genome sequencing for M/XDR tuberculosis surveillance and for resistance testing. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  Diogo F. Veiga,et al.  Genome-Wide Discovery of Small RNAs in Mycobacterium tuberculosis , 2012, PloS one.

[32]  D. Cirillo,et al.  EUSeqMyTB to set standards and build capacity for whole genome sequencing for tuberculosis in the EU. , 2018, The Lancet. Infectious diseases.

[33]  Thomas R Rogers,et al.  Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study , 2016, The Lancet. Respiratory medicine.

[34]  John Crandall,et al.  Validation and Implementation of Clinical Laboratory Improvements Act-Compliant Whole-Genome Sequencing in the Public Health Microbiology Laboratory , 2017, Journal of Clinical Microbiology.

[35]  Ruth McNerney,et al.  A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis , 2017, European Respiratory Journal.

[36]  T. de Oliveira,et al.  Mycobacterium tuberculosis Next-Generation Whole Genome Sequencing: Opportunities and Challenges , 2018, Tuberculosis research and treatment.

[37]  F. Baquero.  Low-level antibacterial resistance: a gateway to clinical resistance. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[38]  Stefan Niemann,et al.  Whole-Genome-Based Mycobacterium tuberculosis Surveillance: a Standardized, Portable, and Expandable Approach , 2014, Journal of Clinical Microbiology.

[39]  Pascal Lapierre,et al.  Comprehensive Whole-Genome Sequencing and Reporting of Drug Resistance Profiles on Clinical Cases of Mycobacterium tuberculosis in New York State , 2017, Journal of Clinical Microbiology.